Add to ORKGTherapeutic drug monitoring of nevirapine in saliva in Uganda using high performance liquid w cost thin-layer load results> 400 copies/mL. Patients with nevirapine concentrations in plasma <3.0 mg/L had an Odds Ratio of Lamorde et al. BMC Infectious Diseases 2014, 14:47
exposure is necessary in order to achieve long-lasting viral suppression. Objectives: To study the i...
Contains fulltext : 87601.pdf (publisher's version ) (Closed access)Kaletra (Abott...
Contains fulltext : 202572.pdf (publisher's version ) (Closed access)Dolutegravir,...
Contains fulltext : 136133.pdf (publisher's version ) (Open Access)BACKGROUND: In ...
Contains fulltext : 70637.pdf (publisher's version ) (Open Access)BACKGROUND: We d...
Item does not contain fulltextBACKGROUND: Thin layer chromatography (TLC) can be used to perform the...
Contains fulltext : 65592_nortcoinc.pdf (publisher's version ) (Open Access)This t...
Contains fulltext : 108828.pdf (publisher's version ) (Open Access)Nevirapine (NVP...
Item does not contain fulltextBACKGROUND: Single-dose nevirapine is a highly cost-effective strategy...
Saliva may provide interesting advantages as matrix for compliance measurements, pharmacokinetic stu...
© 2015 Baxi et al. This is an open access article distributed under the terms of the Creative Common...
Contains fulltext : 169950.pdf (publisher's version ) (Closed access)BACKGROUND: N...
Objectives: To investigate the potential of nevirapine 200 mg once-daily regimen and evaluate the in...
We evaluated whether dried blood spots (DBS) are suitable to monitor combined ART when samples are c...
Background Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral...
exposure is necessary in order to achieve long-lasting viral suppression. Objectives: To study the i...
Contains fulltext : 87601.pdf (publisher's version ) (Closed access)Kaletra (Abott...
Contains fulltext : 202572.pdf (publisher's version ) (Closed access)Dolutegravir,...
Contains fulltext : 136133.pdf (publisher's version ) (Open Access)BACKGROUND: In ...
Contains fulltext : 70637.pdf (publisher's version ) (Open Access)BACKGROUND: We d...
Item does not contain fulltextBACKGROUND: Thin layer chromatography (TLC) can be used to perform the...
Contains fulltext : 65592_nortcoinc.pdf (publisher's version ) (Open Access)This t...
Contains fulltext : 108828.pdf (publisher's version ) (Open Access)Nevirapine (NVP...
Item does not contain fulltextBACKGROUND: Single-dose nevirapine is a highly cost-effective strategy...
Saliva may provide interesting advantages as matrix for compliance measurements, pharmacokinetic stu...
© 2015 Baxi et al. This is an open access article distributed under the terms of the Creative Common...
Contains fulltext : 169950.pdf (publisher's version ) (Closed access)BACKGROUND: N...
Objectives: To investigate the potential of nevirapine 200 mg once-daily regimen and evaluate the in...
We evaluated whether dried blood spots (DBS) are suitable to monitor combined ART when samples are c...
Background Nevirapine extended-release (NVP-XR) taken once daily remains an effective antiretroviral...
exposure is necessary in order to achieve long-lasting viral suppression. Objectives: To study the i...
Contains fulltext : 87601.pdf (publisher's version ) (Closed access)Kaletra (Abott...
Contains fulltext : 202572.pdf (publisher's version ) (Closed access)Dolutegravir,...